ethnopharmacolog
relev
aim
studi
tripterygium
wilfordii
lei
gong
teng
thunder
god
vine
member
celastracea
famili
medicin
plant
use
treat
rang
ill
celastrol
quinon
methid
triterpen
abund
bioactiv
constitu
isol
root
extract
wilfordii
previou
studi
shown
celastrol
exhibit
antivir
activ
hiv
sarscov
date
investig
antidenv
activ
celastrol
report
work
aim
investig
antidenv
effect
possibl
mechan
celastrol
vitro
vivo
method
fourserotyp
denv
infect
system
perform
determin
antidenv
effect
celastrol
detect
denv
rna
replic
protein
synthesi
precis
antidenv
replic
mechan
celastrol
clarifi
use
specif
rna
silenc
specif
inhibitor
addit
therapeut
efficaci
celastrol
evalu
monitor
surviv
rate
clinic
score
denvinfect
institut
cancer
research
icr
suckl
mous
model
result
celastrol
inhibit
rna
replic
ec
valu
mm
respect
antivir
effect
celastrol
associ
celastrolinduc
interferona
ifna
express
attenu
specif
inhibitor
jakestat
signal
pathway
downstream
ifna
specif
shrna
furthermor
celastrol
protect
icr
suckl
mice
lifethreaten
denv
infect
conclus
celastrol
repres
potenti
antidenv
agent
induc
ifna
express
stimul
downstream
antivir
respons
make
therapi
promis
drug
dietari
supplement
treatment
denvinfect
patient
dengu
viru
denv
envelop
viru
belong
flaviviru
genu
flavivirida
famili
base
antigen
divers
denv
divid
four
differ
serotyp
halsey
et
al
viru
rna
genom
translat
polyprotein
subsequ
cleav
host
viru
proteas
least
matur
viral
protein
lee
et
al
three
structur
protein
capsid
prm
envelop
distinguish
denv
serotyp
regul
denv
attach
entri
seven
nonstructur
protein
indispens
denv
replic
highli
conserv
across
denv
serotyp
dalrympl
et
al
denv
arthropodborn
pathogen
propag
mosquito
aed
aegypti
salazar
et
al
denv
infect
caus
spectrum
symptom
rang
acut
selflimit
febril
ill
lifethreaten
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
jone
et
al
ubol
et
al
geograph
rang
dengu
extens
increas
due
urban
global
warm
particularli
tropic
subtrop
area
mcmichael
et
al
approxim
million
peopl
countri
expos
threat
denv
infect
bhatt
et
al
ubol
et
al
current
tetraval
dengu
vaccin
exhibit
limit
efficaci
screaton
et
al
henc
discoveri
altern
strategi
decreas
burden
denv
infect
urgent
need
innat
cellular
immun
respons
especi
interferon
alpha
beta
ifn
ab
mediat
antivir
signal
import
action
viral
replic
pathogenesi
jone
et
al
morrison
et
al
gener
viru
infect
induc
product
secret
type
ifn
interact
cell
surfac
ifna
receptor
virusinfect
nearbi
cell
ifna
receptor
receiv
stimul
type
ifn
lead
activ
kinas
via
tyrosin
phosphoryl
subsequ
signal
transduc
activ
transcript
phosphoryl
form
heterodim
heterodim
transloc
nucleu
bind
ifnstimul
respons
element
isr
lead
upregul
hundr
cellular
gene
induct
antivir
respons
morrison
et
al
convers
knockout
mice
lack
ifn
ab
receptor
exhibit
defici
type
ifn
product
suscept
denv
infect
johnson
roehrig
shresta
et
al
clinic
low
level
type
ifn
observ
patient
sever
dengueassoci
diseas
reveal
ifn
system
play
import
role
prevent
denv
infect
pathogenesi
jone
et
al
ubol
et
al
sever
report
demonstr
ifnstimul
gene
protein
could
inhibit
denv
replic
ifninduc
transmembran
protein
doublestrand
rnadepend
protein
kinas
oligoadenyl
synthetasernas
l
oa
jiang
et
al
simonlorier
et
al
thu
boost
ifnmedi
antivir
respons
might
repres
potent
strategi
denv
infect
tripterygium
wilfordii
lei
gong
teng
thunder
god
vine
member
celastracea
famili
medicin
plant
use
treat
rang
ill
includ
inflamm
swell
fever
sore
pain
use
india
japan
china
korea
asian
countri
time
ju
et
al
lee
et
al
youn
et
al
celastrol
quinon
methid
triterpen
abund
bioactiv
constitu
isol
root
extract
wilfordii
ju
et
al
celastrol
meal
supplement
comprehens
use
herbal
medicin
divers
biolog
activ
antiinflamm
anticanc
hepatoprotect
immunomodul
youn
et
al
moreov
celastrol
exhibit
antivir
activ
hiv
sarscov
via
differ
mechan
ryu
et
al
youn
et
al
date
investig
antidenv
activ
celastrol
report
studi
data
reveal
celastrol
inhibit
denv
replic
upregul
ifna
product
activ
jakestat
signal
hepatoma
cell
celastrol
also
provid
protect
effect
lifethreaten
infect
institut
cancer
research
icr
suckl
mice
experiment
protocol
ratifi
anim
research
committe
kaohsiung
medic
univers
taiwan
iacuc
guidanc
public
health
servic
polici
human
care
use
laboratori
anim
mice
receiv
human
care
fed
standard
rodent
chew
water
ad
libitum
mice
acclimat
standard
laboratori
condit
follow
anim
use
protocol
kaohsiung
medic
univers
week
experi
sixdayold
icr
suckl
mice
use
studi
breeder
mice
icr
strain
obtain
biolasco
taiwan
co
ltd
mice
receiv
human
care
ad
libitum
access
standard
rodent
chew
water
mice
acclimat
standard
laboratori
condit
follow
anim
use
protocol
kaohsiung
medic
univers
week
experi
cell
maintain
dulbecco
modifi
eagl
medium
contain
fetal
bovin
serum
nonessenti
amino
acid
antibioticeantimycot
co
atmospher
c
denv
type
strain
type
strain
type
strain
type
strain
obtain
center
diseas
control
depart
health
taiwan
amplifi
mosquito
cell
hsu
et
al
lee
et
al
celastrol
purchas
fusolmateri
co
ltd
tainan
taiwan
batch
number
hplc
qualiti
control
data
shown
fig
jak
inhibitor
obtain
sigma
st
loui
mo
usa
transfect
reagent
obtain
jifeng
biotechnolog
co
ltd
taipei
taiwan
cell
seed
plate
densiti
cell
per
well
treat
celastrol
indic
concentr
cell
viabil
determin
celltit
aq
ueou
one
solut
cell
prolifer
assay
promega
madison
wi
usa
accord
manufactur
instruct
color
intens
detect
nm
use
biorad
plateread
biorad
hertfordshir
uk
total
cell
rna
extract
use
rna
extract
kit
allbio
co
ltd
taiwan
accord
manufactur
instruct
denv
rna
cellular
mrna
level
analyz
quantit
realtim
reversetranscript
polymeras
chain
reaction
qrtpcr
previous
describ
lee
et
al
rel
denv
rna
level
normal
cellular
dehydrogenas
gapdh
mrna
express
primer
use
studi
list
tabl
western
blot
perform
describ
previous
lee
et
al
brief
mg
cell
lysat
analyz
sdspage
follow
transfer
pvdf
membran
membran
sampl
probe
antidenv
genetex
antigapdh
genetex
cell
signal
antiphosphoryl
cell
signal
cell
signal
antiphosphoryl
antibodi
cell
signal
cell
plate
plate
cell
per
well
viru
collect
cultur
medium
serial
dilut
incub
cell
volum
ml
c
h
incub
ml
dmem
contain
fb
methyl
cellulos
sigmaaldrich
ad
well
day
postinfect
cell
fix
stain
plaqu
assay
solut
crystal
violet
nacl
formalin
c
h
final
viral
titer
calcul
observ
plaqu
format
pisreluc
report
vector
contain
firefli
luciferas
control
isr
use
measur
ifn
responsedepend
transcript
activ
stratagen
agil
technolog
ca
enhanc
green
fluoresc
protein
egfp
shrna
purchas
nation
rnai
core
facil
institut
molecular
biologygenom
research
center
academia
sinica
taiwan
clone
dna
fragment
verifi
dna
sequenc
evalu
transcript
regul
ifn
respons
celastrol
cell
plate
plate
densiti
cell
per
well
transfect
pisreluc
plasmid
use
transfect
reagent
accord
manufactur
instruct
transfect
cell
treat
indic
concentr
celastrol
day
luciferas
activ
tabl
oligonucleotid
sequenc
realtim
rtpcr
sequenc
denv
gene
oligonucleotid
sequenc
gga
aaccaagctgcccatca
ecctccacggatagaagttta
human
gene
oligonucleotid
sequenc
mm
celastrol
day
denv
rna
replic
normal
cellular
gapdh
mrna
level
present
percentag
chang
rel
celastroluntr
control
ifna
sever
posit
control
protein
synthesi
evalu
western
blot
use
antidenv
antibodi
equal
load
cell
lysat
confirm
probe
blot
antigapdh
antibodi
denv
titer
determin
perform
plagu
assay
ifna
sever
posit
control
result
express
mean
sd
error
bar
independ
experi
p
p
analyz
use
steadyglo
luciferas
assay
system
promega
previous
describ
sixdayold
icr
suckl
mice
weigh
g
randomli
divid
three
group
n
follow
group
intracerebr
inject
pfu
c
heatinact
denv
type
strain
idenv
group
intracerebr
inject
pfu
denv
type
strain
ml
salin
denv
group
intracerebr
inject
pfu
denv
type
strain
mgkg
celastrol
denv
celastrol
mice
given
salin
mgkg
celastrol
via
intracerebr
inject
day
postinfect
dpi
surviv
rate
bodi
weight
clinic
score
measur
everi
day
denv
inject
ill
symptom
score
follow
symptom
slight
weight
loss
ruffl
hair
slow
activ
asthenia
anorexia
paralysi
mortal
ill
death
dpi
mice
sacrif
co
asphyxi
g
brain
tissu
harvest
use
trizol
rna
collect
data
present
mean
standard
deviat
least
three
independ
experi
statist
signific
analyz
use
student
ttest
celastrol
quinon
methid
triterpen
fig
possess
divers
biolog
activ
ju
et
al
lee
et
al
treat
mm
celastrol
day
denv
rna
replic
normal
cellular
gapdh
mrna
level
present
percentag
chang
rel
celastroluntr
control
result
express
mean
sd
error
bar
independ
experi
p
fig
celastrol
protect
icr
suckl
mice
lifethreaten
denv
infect
sixdayold
icr
suckl
mice
weigh
g
randomli
divid
three
group
group
intracerebr
inject
pfu
c
heatinact
denv
ml
salin
day
postinfect
dpi
neg
control
idenv
group
intracerebr
inject
pfu
denv
ml
salin
dpi
posit
control
denv
group
intracerebr
inject
pfu
denv
celastrol
mgkg
dpi
surviv
rate
b
clinic
score
c
bodi
weight
measur
everi
day
denv
inject
symptom
score
follow
symptom
slight
weight
loss
ruffl
hair
slow
activ
asthenia
anorexia
paralysi
mortal
ill
death
mice
control
group
treat
c
heatinact
denv
min
group
includ
mice
cell
treat
mm
celastrol
indic
time
h
total
protein
assay
western
blot
use
antigapdh
load
control
antibodi
band
intens
quantifi
densitometr
scan
present
fold
valu
rel
h
measur
defin
follow
normal
gapdh
protein
level
b
shrna
restor
antidenv
effect
celastrol
cell
transfect
shrna
mg
egfp
mg
follow
denv
infect
celastrol
treatment
day
protein
synthesi
evalu
western
blot
use
antidenv
antibodi
antibodi
antibodi
equal
load
cell
lysat
confirm
probe
blot
antigapdh
antibodi
c
jak
inhibitor
shrna
restor
antidenv
effect
celastrol
cell
transfect
shrna
mg
treat
jak
inhibitor
mm
cell
infect
denv
treat
mm
celastrol
day
protein
synthesi
evalu
western
blot
use
antidenv
antibodi
antibodi
antibodi
equal
load
cell
lysat
confirm
probe
blot
antigapdh
antibodi
investig
whether
celastrol
exhibit
antidenv
activ
treat
cell
drug
variou
concentr
day
qrtpcr
analysi
perform
evalu
inhibitori
effect
celastrol
denv
rna
replic
meantim
cytotox
effect
denvinfect
cell
fig
cell
fig
test
use
mt
assay
shown
fig
celastrol
proport
reduc
denv
rna
replic
effect
concentr
ec
mm
cytotox
effect
antivir
concentr
western
blot
perform
evalu
inhibitori
effect
celastrol
denv
protein
synthesi
similar
result
denv
rna
replic
celastrol
concentrationdepend
reduc
denv
protein
level
fig
addit
celastrol
concentrationdepend
decreas
viral
titer
compar
celastroluntr
cell
fig
examin
inhibitori
effect
celastrol
rna
replic
differ
denv
serotyp
cell
infect
denvinfect
cell
treat
celastrol
variou
concentr
day
denv
rna
replic
analyz
qrtpcr
analysi
shown
fig
celastrol
inhibit
rna
replic
ec
valu
mm
respect
investig
whether
celastrol
also
exhibit
antidenv
activ
vivo
employ
denvinfect
icr
suckl
mice
examin
protect
effect
celastrol
lifethreaten
denv
infect
sixdayold
icr
suckl
mice
weigh
g
randomli
divid
three
group
surviv
rate
clinic
score
bodi
weight
denvinject
mice
treat
without
celastrol
measur
daili
day
rel
idenv
group
sever
ill
lead
death
within
day
dpi
note
denv
group
contrast
celastrol
concentr
mgkg
protect
mice
lifethreaten
infect
compar
noncelastroletr
mice
fig
day
observ
anim
denv
group
exhibit
sever
asthenia
paralysi
bodi
weight
loss
compar
idenv
group
fig
c
convers
celastroltr
group
display
slight
asthenia
paralysi
bodi
weight
loss
compar
idenv
group
dpi
fig
c
result
reveal
celastrol
exert
protect
effect
lethal
relat
ill
numer
report
demonstr
celastrol
exert
immunomodulatori
effect
ryu
et
al
seo
et
al
determin
whether
celastrol
could
induc
ifna
express
via
effect
measur
rna
express
ifna
protein
secret
cell
treat
celastrol
increas
concentr
day
qrtpcr
analysi
perform
evalu
gene
express
shown
fig
celastrol
concentrationdepend
induc
rna
express
compar
find
noncelastroltr
cell
induct
effect
rna
express
celastrol
also
observ
huh
celastrol
day
luciferas
activ
measur
determin
isr
promot
activ
present
fold
activ
rel
celastroluntr
cell
defin
celastrol
induc
rna
transcript
b
c
denvinfect
cell
cell
seed
plate
infect
moi
h
cell
treat
mm
celastrol
day
total
rna
harvest
qrtpcr
specif
primer
rna
level
normal
cellular
gapdh
mrna
level
present
percentag
chang
rel
celastroluntr
control
result
express
mean
sd
error
bar
independ
experi
p
p
cell
fig
addit
ifna
protein
level
supernat
measur
elisa
experiment
condit
expect
celastrol
induc
ifna
protein
secret
supernat
concentrationdepend
manner
fig
ifna
interact
cell
surfac
ifna
receptor
activ
kinas
fink
grandvaux
katz
et
al
lead
phosphoryl
transloc
darnel
schindler
strehlow
confirm
whether
celastrol
stimul
jakestat
pathway
first
treat
denvinfect
cell
celastrol
mm
differ
time
period
phosphoryl
level
analyz
western
blot
shown
fig
celastrol
treatment
increas
level
phosphoryl
time
depend
manner
confirm
role
celastrol
antidenv
activ
shrna
employ
silenc
express
shown
fig
celastrol
effect
reduc
denv
protein
replic
lane
shrna
lane
partial
restor
antidenv
effect
celastrol
rel
deplet
alon
deplet
exert
restor
effect
denv
protein
replic
lane
clarifi
contribut
celastrolinduc
ifna
express
phosphoryl
upstream
kinas
inhibit
use
inhibitor
shrna
shown
fig
inhibitor
effect
attenu
antidenv
effect
celastrol
compar
find
celastroltr
untreat
cell
lane
shrna
exert
restor
effect
denv
protein
replic
lane
data
indic
antidenv
activ
celastrol
mediat
ifna
upon
phosphoryl
transloc
bind
isr
lead
upregul
downstream
antivir
gene
mccomb
et
al
perri
et
al
determin
whether
celastrolinduc
ifna
could
activ
downstream
antivir
gene
isr
activ
gene
express
measur
denvinfect
cell
transfect
isredriven
firefli
luciferas
report
plasmid
follow
treatment
celastrol
day
shown
fig
celastrol
increas
isr
promot
activ
approxim
determin
luciferas
activ
furthermor
critic
ifnstimul
gene
viral
infect
gene
express
examin
shown
fig
significantli
upregul
celastrol
concentrationdepend
manner
confirm
celastrol
exhibit
ifnmodul
activ
vivo
brain
tissu
collect
analyz
ifn
oa
gene
express
shown
fig
b
gene
express
level
significantli
increas
celastroltr
mice
compar
level
untreat
denvinfect
mice
dpi
data
suggest
celastrol
preferenti
induc
antivir
interferon
gene
express
denvinfect
icr
suckl
mice
present
studi
data
clearli
demonstr
celastrol
strongli
suppress
denv
serotyp
replic
fig
addit
celastrol
effect
reduc
clinic
score
protect
icr
suckl
mice
lifethreaten
denv
infect
fig
studi
comprehens
antidenv
mechan
celastrol
demonstr
antivir
ifn
respons
thoroughli
investig
data
indic
antivir
activ
celastrol
denvinfect
cell
occur
togeth
upregul
ifna
express
fig
echo
find
diamond
et
al
ifn
modul
denvinfect
human
cell
diamond
et
al
retino
acid
induc
gene
signal
pathway
downstream
molecul
mitochondri
antivir
signal
ifn
regulatori
factor
critic
ifn
product
nasirudeen
et
al
futur
studi
perform
determin
ifnactiv
pathway
contribut
antidenv
effect
celastrol
obtain
addit
inform
design
antidenv
agent
result
reveal
activ
contribut
antidenv
activ
celastrol
fig
moreov
found
oa
gene
famili
downstream
stimul
celastrol
fig
similar
result
observ
denvinfect
icr
suckl
mous
brain
tissu
fig
basi
find
present
studi
propos
model
demonstr
action
celastrol
denv
infect
fig
simonlorier
et
al
demonstr
oa
gene
famili
exhibit
high
antidenv
activ
fig
celastrol
induc
antivir
ifn
respons
denvinfect
icr
suckl
mice
vivo
sixdayold
icr
suckl
mice
inocul
pfu
intracerebr
inject
administ
celastrol
mgkg
dpi
g
brain
tissu
harvest
trizol
rna
collect
ifna
b
oa
famili
gene
express
level
measur
qrtpcr
specif
primer
rna
level
normal
cellular
gapdh
mrna
level
present
fold
chang
rel
celastroluntr
control
defin
idenv
group
subject
c
heatinactiv
denv
min
number
mice
group
rang
data
support
find
simonlorier
et
al
howev
denv
infect
result
inhibit
antivir
ifn
signal
attribut
denv
proteasemedi
cleavag
human
mediat
activ
mita
yu
et
al
inhibit
phosphoryl
dalrympl
et
al
replicasemedi
inhibit
express
morrison
et
al
inhibitori
effect
celastrol
denv
proteas
replicas
might
part
contribut
antidenv
activ
hypothesi
investig
futur
decad
numer
group
intend
develop
directact
antivir
daa
treat
denv
infect
howev
high
replic
rate
denv
low
fidel
rna
polymeras
may
lead
daaresist
variant
repres
major
challeng
antidenv
daa
develop
lim
et
al
addit
efficaci
daa
differ
serotyp
denv
may
differ
lim
et
al
therefor
enhanc
host
innat
immun
exert
protect
effect
denv
progress
ifn
activ
repres
potenti
tactic
avoid
drug
resist
effect
genet
variabl
viral
genom
lim
et
al
morrison
et
al
numer
studi
illustr
type
ifn
involv
pathogenesi
denv
infect
progress
undifferenti
febril
ill
df
lifethreaten
infect
dhfdss
jone
et
al
ubol
et
al
viral
load
circul
level
denv
antigen
import
differ
df
dhf
patient
chuang
et
al
halstead
high
circul
level
denv
antigen
result
enhanc
denv
infect
via
virusantibodi
complex
furthermor
intracellular
innat
respons
denv
suppress
interact
virusantibodi
complex
fc
receptor
chareonsirisuthigul
et
al
huang
et
al
result
increas
denv
replic
progress
dhf
dss
halstead
therefor
celastrolinduc
ifn
may
function
potenti
antidenv
factor
exert
cytoprotect
effect
denvassoci
cell
damag
lifethreaten
symptom
associ
dhf
dss
studi
necessari
elucid
effect
celastrol
pathogenesi
denv
infect
progress
dhf
dss
summari
celastrol
markedli
inhibit
denv
replic
upregul
ifn
express
activ
downstream
jakstat
signal
result
express
ifnstimul
oa
gene
may
repres
therapeut
tactic
denv
infect
celastrol
consid
promis
drug
dietari
supplement
treatment
denvinfect
patient
grate
acknowledg
dr
charl
rice
rockefel
univers
aapth
lcc
usa
kindli
support
human
hepatoma
cell
center
diseas
control
depart
health
taiwan
kindli
support
serotyp
dengu
viru
supplementari
data
relat
articl
found
http
